National Institutes of Health, National Cancer Institute, Division of Extramural Activities - Home Page
NIH NCI DEA Logo NIH NCI NCI/DEA
Clinical Trials and Translational Research Advisory Committee

Presentations from the Meeting Held July 11, 2018
(Presentation File Format - PDF --> Get Adobe Reader)

July 11
NIH VIDEOCAST  

CALL TO ORDER AND OPENING REMARKS  
Call to Order and Opening Remarks Dr. Davidson

NCI DEPUTY DIRECTOR'S UPDATE  
NCI Deputy Director's Update
2009 2018 NCI Cancer Clinical Investigator Team Leadership Award (CCITLA) Recipients
Dr. Doroshow

LEGISLATIVE UPDATE  
Legislative Update
Legislative Report
Ms. Holohan

THE QUANTITATIVE IMAGING NETWORK (QIN)  
The Quantitative Imaging Network (QIN) Dr. Nordstrom

RETIRING CTAC MEMBERS' RECOGNITION  
Retiring CTAC Members' Recognition Dr. Doroshow

CANCER IMMUNE MONITORING ANALYSIS CENTERS (CIMAC) UPDATE  
Cancer Immune Monitoring Analysis Centers (CIMAC) Update Dr. Chen

THE LANCET HAEMATOLOGY COMMISSION  
Beyond Maximum Grade: Modernizing the Assessment and Reporting of Adverse Events
Beyond Maximum Grade: NCI-related Activities in Tolerability of Cancer Treatment
The Lancet Haematology Commission on Adverse Events Report
Dr. Thanarajasingam
Dr. Minisian

ADULT EXPERIMENTAL THERAPEUTICS TOPICS  
Evaluation of the Experimental Therapeutics Clinical Trials Network (ETCTN)
ETCTN
ETCTN Portfolio of Brain Cancer Trials
ETCTN Brain Trials
Physician Fact Sheet: For Patients with Metastic Castrate Resistant Prostate Cancer
ETCTN NCI Drug Development Project Teams
Investigational Drug Steering Committee (IDSC)
Dr. Massett
Dr. Ivy



Dr. Shapiro
Drs. Carducci & Lara

PEDIATRIC EARLY PHASE CLINICAL TRIALS NETWORK  
Pediatric Early Phase Clinical Trials Network Dr. Smith

ONGOING AND NEW BUSINESS  
Ongoing and New Business Dr. Davidson

Top